Showing results (1491-1500 of 10,068) with videos related to
Sort By:
Pageof 1,007
Vaccines|February 28, 2023
Assessment of the Interferon-Lambda-3 Polymorphism in the Antibody Response to COVID-19 in Older Adults Seropositive for CMVAriane Nardy, Camila Tussato Soares Camargo, Yasmim Faustina Castro de Oliveira, et al.Vaccines|February 28, 2023
Effectiveness and Safety of COVID-19 Vaccination in Patients with Malignant DiseaseLi Zhao, Lin Fu, Yuqin He, et al.Vaccines|February 28, 2023
A Synthetic Biology Approach for Vaccine Candidate Design against Delta Strain of SARS-CoV-2 Revealed Disruption of Favored Codon Pair as a Better Strategy over Using Rare CodonsPankaj Gurjar, Noushad Karuvantevida, Igor Vladimirovich Rzhepakovsky, et al.Vaccines|February 28, 2023
Respiratory Syncytial Virus Infection: Treatments and Clinical ManagementShiza Malik, Tahir Ahmad, Khalid Muhammad, et al.Vaccines|November 11, 2022
Short-Term Adverse Effects Following Booster Dose of Inactivated-Virus vs. Adenoviral-Vector COVID-19 Vaccines in Algeria: A Cross-Sectional Study of the General PopulationMohamed Lounis, Hani Amir Aouissi, Samir Abdelhadi, et al.Vaccines|November 11, 2022
Cellular and Humoral SARS-CoV-2 Vaccination Responses in 192 Adult Recipients of Allogeneic Hematopoietic Cell TransplantationThomas Meyer, Gabriele Ihorst, Ingrid Bartsch, et al.Vaccines|November 11, 2022
Malaysian Parents' Willingness to Vaccinate Their Children against COVID-19 Infection and Their Perception of mRNA COVID-19 VaccinesLi-Ping Wong, Hai-Yen Lee, Haridah Alias, et al.Vaccines|November 11, 2022
COVID-19 Vaccine-Related Vogt-Koyanagi-Harada Disease Complicated by Central Serous Chorioretinopathy during Treatment Course: Case Report and Literature ReviewRuyi Han, Gezhi Xu, Xinyi DingVaccines|November 11, 2022
Can a Two-Dose Influenza Vaccine Regimen Better Protect Older Adults? An Agent-Based Modeling StudyKatherine V Williams, Mary G Krauland, Lee H Harrison, et al.Vaccines|November 11, 2022
Safety and Viral Shedding of Live Attenuated Influenza Vaccine (LAIV) in Chinese Healthy Juveniles and Adults: A Phase Ⅰ Randomized, Double-Blind, Placebo-Controlled StudyLi Li, Nianmin Shi, Na Xu, et al.Pageof 1,007